{
  "id": 20543276,
  "title": "Cogstate at Bell Potter Healthcare Conference: medidata deal lifts outlook",
  "url": "https://urgent.news/2026/11/18/cogstate-at-bell-potter-healthcare-conference-medidata-deal-lifts",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T04:05:10.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/cogstate-at-bell-potter-healthcare-conference-medidata-deal-lifts-outlook-93CH-5034664"
  },
  "original_language": "en",
  "account": "Cogstate, a clinical trial technology group, showcased its robust growth and financial health during the Bell Potter Healthcare Conference. The ASX-listed company reported FY 2026 revenue of $60.9 million, with EBIT margins of 25% and a profit before tax of $16 million. Cogstate's contracted revenue reached $143.7 million as of September 30, 2026, with $56.9 million already secured for FY 2027. The company is well-funded, with $35 million in net cash and no debt, and it continues to execute buybacks and dividends.\n\nCogstate's partnership with Medidata, a large SaaS provider, is reshaping how it reaches drug makers, particularly in central nervous system (CNS) studies. This collaboration provides access to Medidata's extensive customer base and commercial force, enhancing the company's chances of winning phase III trials. The company has managed 171 clinical trials, with a phase II pipeline growing sharply to 78 trials as of June 30, 2026. Cogstate's unique value lies in its ability to reduce error and noise in clinical trial data, improving the accuracy of treatment effectiveness assessments. The company's services are especially crucial in CNS trials, where endpoints are often subjective.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}